-- 
Merck, J&J’s Simponi Backed in Final U.K. Arthritis Guidelines

-- B y   K r i s t e n   H a l l a m
-- 
2011-04-27T09:37:56Z

-- http://www.bloomberg.com/news/2011-04-27/merck-j-j-s-simponi-backed-in-final-u-k-arthritis-guidelines.html
Merck & Co. and  Johnson & Johnson (JNJ) ’s
Simponi won the recommendation of the U.K. National Institute
for Health and Clinical Excellence in final guidance on the
treatment of psoriatic arthritis, the agency, known as NICE,
said today in an e-mailed statement.  To contact the editor responsible for this story:
Kristen Hallam at 
 khallam@bloomberg.net  